Simplex Trading
IBRX icon

Simplex Trading’s ImmunityBio IBRX Stock Holding History

Simplex Trading’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.76M Buy
489,700
+191,400
+64% +$1.31M ﹤0.01% 1326
2025
Q4 		$591K Buy
298,300
+154,200
+107% +$349K ﹤0.01% 3137
2025
Q3 		$354K Sell
144,100
-191,700
-57% -$494K ﹤0.01% 4260
2025
Q2 		$827K Sell
335,800
-500
-0.1% -$1.34K ﹤0.01% 2975
2025
Q1 		$1.01M Buy
336,300
+100,300
+43% +$304K ﹤0.01% 2699
2024
Q4 		$604K Buy
236,000
+51,400
+28% +$214K ﹤0.01% 3330
2024
Q3 		$686K Sell
184,600
-74,300
-29% -$344K ﹤0.01% 3268
2024
Q2 		$1.64M Sell
258,900
-94,200
-27% -$621K ﹤0.01% 2396
2024
Q1 		$1.9M Buy
353,100
+266,700
+309% +$1.21M ﹤0.01% 2456
2023
Q4 		$433K Sell
86,400
-127,200
-60% -$399K ﹤0.01% 3849
2023
Q3 		$360K Sell
213,600
-14,700
-6% -$29.5K ﹤0.01% 3742
2023
Q2 		$634K Buy
228,300
+150,000
+192% +$424K ﹤0.01% 3061
2023
Q1 		$142K Buy
78,300
+58,900
+304% +$183K ﹤0.01% 4740
2022
Q4 		$98K Sell
19,400
-59,700
-75% -$328K ﹤0.01% 5097
2022
Q3 		$393K Buy
79,100
+55,700
+238% +$254K ﹤0.01% 3748
2022
Q2 		$87K Sell
23,400
-54,500
-70% -$219K ﹤0.01% 5755
2022
Q1 		$437K Sell
77,900
-5,400
-6% -$33.1K ﹤0.01% 4003
2021
Q4 		$506K Buy
83,300
+24,200
+41% +$182K ﹤0.01% 3789
2021
Q3 		$841K Hold
59,100
– – ﹤0.01% 3328
2021
Q2 		$843K Buy
59,100
+58,228
+6,678% +$962K ﹤0.01% 3375
2021
Q1 		$2.07M Sell
872
-306
-26% -$7.93K ﹤0.01% 1565
2020
Q4 		$1.57M Buy
1,178
+695
+144% +$6.68K ﹤0.01% 2022
2020
Q3 		$334K Sell
483
-286
-37% -$2.85K ﹤0.01% 3484
2020
Q2 		$944K Buy
769
+651
+552% +$3.68K ﹤0.01% 2200
2020
Q1 		$33K Sell
118
-48
-29% -$240 ﹤0.01% 5547
2019
Q4 		$62K Buy
+166
New +$282 ﹤0.01% 5001
2019
Q3 		– Sell
-162
Closed -$16K – 7518
2019
Q2 		$16K Sell
162
-135
-45% -$156 ﹤0.01% 5785
2019
Q1 		$46K Buy
297
+149
+101% +$187 ﹤0.01% 5068
2018
Q4 		$17K Buy
+148
New +$339 ﹤0.01% 5458
2018
Q1 		– Sell
-145
Closed -$76K – 6453
2017
Q4 		$76K Sell
145
-105
-42% -$497 ﹤0.01% 2043
2017
Q3 		$46K Buy
250
+242
+3,025% +$1.49K ﹤0.01% 2374
2017
Q2 		$2K Buy
+8
New +$35 ﹤0.01% 5259
2016
Q3 		– Sell
-15
Closed -$9K – 6069
2016
Q2 		$9K Buy
15
+5
+50% +$39 ﹤0.01% 3683
2016
Q1 		$4K Buy
10
+9
+900% +$85 ﹤0.01% 4254
2015
Q4 		$1K Sell
1
-15
-94% -$223 ﹤0.01% 4883
2015
Q3 		$8K Buy
+16
New +$349 ﹤0.01% 3635

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Simplex Trading's IBRX Position: Q1 2026 in Review

Simplex Trading sold out of ImmunityBio (IBRX) in Q1 2026, closing a stake of 493,445 shares — an estimated $3.38M sold.

Simplex Trading first reported a position in IBRX in Q3 2015 and held it in 28 quarters. The position peaked at $977K in Q4 2025. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Simplex Trading reported no remaining ImmunityBio position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 493,445 ImmunityBio shares in Q1 2026, an estimated $3.38M.
  • Simplex Trading first reported a position in ImmunityBio in Q3 2015 and held it in 28 quarters.
  • Simplex Trading's ImmunityBio position peaked at $977K in Q4 2025.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.